Sumitomo Pharma Co. Ltd.

In News

Sumitomo Pharma Profit Surges on Higher Revenue and Cost Controls - TipRanks

TipRanks - May 13, 2026

Sumitomo Chemical : Notice Concerning Variances between the Non-consolidated Financial Results in a Consolidated Subsidiary (Sumitomo Pharma Co., Ltd.) for Fiscal Year 2025 and 2024 - marketscreener.com

marketscreener.com - May 13, 2026

Sumitomo Pharma Issues Cautious FY2025 Results Conference Materials - TipRanks

TipRanks - May 13, 2026

Sumitomo Pharma America to Present New Investigational Data at the 2025 American Society of Hematology Annual Meeting - PR Newswire

PR Newswire - Nov 03, 2025

Sumitomo Pharma Co Ltd- Notice Regarding Withdrawal Of Shelf Registration Statement For Issuance Of New Shares - TradingView

TradingView - Apr 27, 2026

Cytonome Congratulates Sumitomo Pharma on Regulatory Approval for Regenerative Medicine Therapy for Parkinson’s disease - BioInformant

BioInformant - Mar 11, 2026

Sumitomo Pharma shares slide nearly 16% despite panel backing for iPS-derived parkinson’s treatment - Seeking Alpha

Seeking Alpha - Feb 20, 2026

MSN Money - MSN

MSN - May 09, 2026

Optimistic Investors Push Sumitomo Pharma Co., Ltd. (TSE:4506) Shares Up 26% But Growth Is Lacking - simplywall.st

simplywall.st - Jan 10, 2026

Sumitomo Pharma Profit Jumps on U.S. Asset Transfer and Asian Stake Sale - TipRanks

TipRanks - May 13, 2026

Sumitomo Pharma Shares Drop After Stem-Therapy Backing - Bloomberg.com

Bloomberg.com - Feb 19, 2026

Sumitomo Pharma Q3 FY2025 slides: North American sales drive 408% profit surge - Investing.com

Investing.com - Feb 06, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment